4//SEC Filing
Pierce Valerie L 4
Accession 0001209191-23-016377
CIK 0001426332other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:03 PM ET
Size
9.9 KB
Accession
0001209191-23-016377
Insider Transaction Report
Form 4
Pierce Valerie L
SVP, GC & CCO
Transactions
- Award
Common Stock
2023-03-02+49,000→ 55,667 total - Award
Stock Option (Right to Buy)
2023-03-02+147,000→ 147,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (147,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-02+150,000→ 150,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (150,000 underlying)
Footnotes (4)
- [F1]Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
- [F2]Includes 1,805 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on May 14, 2021 and 1,252 ESPP shares acquired on May 13, 2022.
- [F3]The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
- [F4]1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001397112
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:03 PM ET
- Size
- 9.9 KB